Virtus ETF Advisers LLC Igm Biosciences, Inc. Transaction History

Virtus ETF Advisers LLC

$234 Million
Q4 2024

A detailed history of Virtus ETF Advisers LLC transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 8,649 shares of IGMS stock, worth $10,724. This represents 0.02% of its overall portfolio holdings.

Number of Shares

8,649

Previous 11,606 25.48%

Holding current value

$10,724

Previous $191,000 72.77%

% of portfolio

0.02%

Previous 0.09%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$6.05 - $17.83 $17,889 - $52,723	-2,957 Reduced 25.48%	8,649 $52,000
Q3 2024 Nov 14, 2024	BUY	$6.28 - $17.68 $1,287 - $3,624	205 Added 1.8%	11,606 $191,000
Q2 2024 Aug 14, 2024	SELL	$6.51 - $11.47 $12,570 - $22,148	-1,931 Reduced 14.48%	11,401 $78,000
Q1 2024 May 15, 2024	SELL	$8.68 - $17.36 $7,907 - $15,814	-911 Reduced 6.4%	13,332 $128,000
Q4 2023 Feb 15, 2024	BUY	$3.94 - $8.79 $17,075 - $38,095	4,334 Added 43.74%	14,243 $118,000
Q3 2023 Nov 07, 2023	SELL	$6.66 - $10.64 $6,573 - $10,501	-987 Reduced 9.06%	9,909 $82,000
Q2 2023 Aug 14, 2023	BUY	$8.86 - $14.0 $51,237 - $80,962	5,783 Added 113.1%	10,896 $100,000
Q1 2023 May 15, 2023	SELL	$13.74 - $25.76 $26,999 - $50,618	-1,965 Reduced 27.76%	5,113 $70,000
Q4 2022 Feb 14, 2023	SELL	$15.45 - $26.02 $3,723 - $6,270	-241 Reduced 3.29%	7,078 $120,000
Q3 2022 Nov 14, 2022	BUY	$15.42 - $27.01 $801 - $1,404	52 Added 0.72%	7,319 $166,000
Q2 2022 Aug 12, 2022	BUY	$13.27 - $25.5 $23,859 - $45,849	1,798 Added 32.88%	7,267 $131,000
Q1 2022 May 16, 2022	SELL	$13.42 - $29.73 $4,267 - $9,454	-318 Reduced 5.5%	5,469 $146,000
Q4 2021 Feb 14, 2022	BUY	$27.59 - $66.39 $98,606 - $237,277	3,574 Added 161.5%	5,787 $170,000
Q3 2021 Nov 15, 2021	SELL	$65.76 - $90.65 $7,562 - $10,424	-115 Reduced 4.94%	2,213 $146,000
Q2 2021 Aug 10, 2021	SELL	$57.98 - $96.6 $64,125 - $106,839	-1,106 Reduced 32.21%	2,328 $194,000
Q1 2021 May 17, 2021	BUY	$71.56 - $121.23 $4,293 - $7,273	60 Added 1.78%	3,434 $263,000
Q4 2020 Feb 12, 2021	SELL	$47.41 - $115.03 $73,912 - $179,331	-1,559 Reduced 31.6%	3,374 $298,000
Q3 2020 Nov 13, 2020	SELL	$43.0 - $84.01 $28,337 - $55,362	-659 Reduced 11.78%	4,933 $364,000
Q2 2020 Aug 05, 2020	BUY	$51.3 - $75.21 $286,869 - $420,574	5,592 New	5,592 $408,000

Others Institutions Holding IGMS

# of Institutions

Shares Held

19.5M

Call Options Held

61.3K

Put Options Held

36.7K

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $35.9M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Igm Biosciences, Inc. Transaction History